StockNews.com lowered shares of CorVel (NASDAQ:CRVL – Free Report) from a buy rating to a hold rating in a research report sent to investors on Friday.
CorVel Stock Performance
CRVL opened at $242.51 on Friday. CorVel has a one year low of $187.92 and a one year high of $265.14. The stock’s fifty day moving average is $243.19 and its 200-day moving average is $232.03. The company has a market capitalization of $4.15 billion, a PE ratio of 56.14 and a beta of 1.08.
Insider Transactions at CorVel
In other news, Director Steven J. Hamerslag sold 2,000 shares of the business’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $239.95, for a total transaction of $479,900.00. Following the sale, the director now directly owns 114,389 shares of the company’s stock, valued at $27,447,640.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Steven J. Hamerslag sold 2,000 shares of CorVel stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $239.95, for a total transaction of $479,900.00. Following the transaction, the director now owns 114,389 shares in the company, valued at $27,447,640.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Chairman V Gordon Clemons sold 1,000 shares of CorVel stock in a transaction on Monday, February 12th. The shares were sold at an average price of $248.00, for a total value of $248,000.00. Following the transaction, the chairman now owns 312,534 shares in the company, valued at approximately $77,508,432. The disclosure for this sale can be found here. Insiders have sold 11,543 shares of company stock valued at $2,881,792 over the last three months. Company insiders own 48.71% of the company’s stock.
Hedge Funds Weigh In On CorVel
CorVel Company Profile
CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.
See Also
- Five stocks we like better than CorVel
- 3 Fintech Stocks With Good 2021 Prospects
- Brinker International Heats Up on Spicy Earnings Beat and Raise
- Dividend Payout Ratio Calculator
- Eli Lilly Gains on the GLP-1 Weight Loss Phenomenon
- Investing in large cap stocks: Diving into big caps
- Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.